Dwight E. Ellingwood - 31 Jan 2023 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC

Role
Director
Signature
/s/ F. Mark Reuter, as Attorney-in-fact for Dwight Ellingwood
Issuer symbol
N/A
Transactions as of
31 Jan 2023
Net transactions value
-$1,483,241
Form type
4
Filing time
31 Jan 2023, 13:17:14 UTC
Previous filing
28 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIVO Common Stock Disposed to Issuer -17,290 -100% 0 31 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVO Stock Option (Right to Buy) Disposed to Issuer $112,200 -8,500 -100% $13.20 0 31 Jan 2023 Common Stock 8,500 $20.80 Direct F2
transaction VIVO Stock Option (Right to Buy) Disposed to Issuer $91,630 -5,500 -100% $16.66 0 31 Jan 2023 Common Stock 5,500 $17.34 Direct F3
transaction VIVO Stock Option (Right to Buy) Disposed to Issuer $130,560 -8,500 -100% $15.36 0 31 Jan 2023 Common Stock 8,500 $18.64 Direct F4
transaction VIVO Stock Option (Right to Buy) Disposed to Issuer $233,200 -11,000 -100% $21.20 0 31 Jan 2023 Common Stock 11,000 $12.80 Direct F5
transaction VIVO Stock Option (Right to Buy) Disposed to Issuer $213,600 -12,000 -100% $17.80 0 31 Jan 2023 Common Stock 12,000 $16.20 Direct F6
transaction VIVO Stock Option (Right to Buy) Disposed to Issuer $148,842 -8,740 -100% $17.03 0 31 Jan 2023 Common Stock 8,740 $16.97 Direct F7
transaction VIVO Stock Option (Right to Buy) Disposed to Issuer $405,006 -17,205 -100% $23.54 0 31 Jan 2023 Common Stock 17,205 $10.46 Direct F8
transaction VIVO Stock Option (Right to Buy) Disposed to Issuer $73,261 -5,796 -100% $12.64 0 31 Jan 2023 Common Stock 5,796 $21.36 Direct F9
transaction VIVO Stock Option (Right to Buy) Disposed to Issuer $74,942 -5,656 -100% $13.25 0 31 Jan 2023 Common Stock 5,656 $20.75 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Dwight E. Ellingwood is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The shares were disposed of pursuant to the Agreement and Plan of Merger dated as of July 7, 2022 (the "Merger Agreement") by and among the Issuer and SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea whereby, immediately prior to the effective time of the merger contemplated therein (the "Effective Time"), all issued and outstanding shares of Issuer common stock were converted into the right to receive $34.00 per share in cash and, when so converted, automatically cancelled.
F2 The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment.
F3 The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment.
F4 The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment.
F5 The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment.
F6 The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment.
F7 The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment.
F8 The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment.
F9 The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment.
F10 The Stock Option vested in full and was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the difference between the per share exercise price of the option and the $34.00 per share merger consideration, less all applicable deductions and withholdings required to be withheld in respect of such payment.